Largest Study of its Kind Finds Guardant360 MSI Highly Concordant to Tissue

    NEXT STORY
    SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast
    PREV STORY
    Influenza Diagnostic Tests Market to hit $1.5 billion by 2025: Global Market Insights, Inc.
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combination of AFM24, an EGFR Targeted Innate Cell Engager, with SNK-01 Natural Killer Cell Therapy in Solid Tumors

    author_avatar
    NASDAQ Market News

    Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017

    RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News